{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:06:24Z","timestamp":1791972384553,"version":"4.3.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T00:00:00Z","timestamp":1408665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00415-014-7385-9","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T10:11:28Z","timestamp":1408615888000},"page":"542-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":133,"title":["Central ocular motor disorders, including gaze palsy and nystagmus"],"prefix":"10.1007","volume":"261","author":[{"given":"M.","family":"Strupp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Kremmyda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Adamczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Muth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. W.","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bremova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,22]]},"reference":[{"key":"7385_CR1","volume-title":"The neurology of eye movements","author":"RJ Leigh","year":"2006","unstructured":"Leigh RJ, Zee D (2006) The neurology of eye movements. Oxford University Press, Oxford"},{"key":"7385_CR2","first-page":"197","volume":"108","author":"M Strupp","year":"2011","unstructured":"Strupp M, Hufner K, Sandmann R, Zwergal A, Dieterich M, Jahn K, Brandt T (2011) Central oculomotor disturbances and nystagmus: a window into the brainstem and cerebellum. Dtsch Arztebl Int 108:197\u2013204","journal-title":"Dtsch Arztebl Int"},{"key":"7385_CR3","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-85729-591-0","volume-title":"Vertigo and dizziness\u2014common complaints","author":"T Brandt","year":"2013","unstructured":"Brandt T, Dieterich M, Strupp M (2013) Vertigo and dizziness\u2014common complaints, 2nd edn. Springer, London","edition":"2"},{"key":"7385_CR4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/jnnp.2007.123596","volume":"79","author":"CD Cnyrim","year":"2008","unstructured":"Cnyrim CD, Newman-Toker D, Karch C, Brandt T, Strupp M (2008) Bedside differentiation of vestibular neuritis from central \u201cvestibular pseudoneuritis\u201d. J Neurol Neurosurg Psychiatry 79:458\u2013460","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7385_CR5","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1161\/STROKEAHA.109.551234","volume":"40","author":"JC Kattah","year":"2009","unstructured":"Kattah JC, Talkad AV, Wang DZ, Hsieh YH, Newman-Toker DE (2009) HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke 40:3504\u20133510","journal-title":"Stroke"},{"key":"7385_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(08)00601-8","volume":"171","author":"JA Buttner-Ennever","year":"2008","unstructured":"Buttner-Ennever JA (2008) Mapping the oculomotor system. Prog Brain Res 171:3\u201311","journal-title":"Prog Brain Res"},{"key":"7385_CR7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/brain\/110.3.649","volume":"110","author":"T Brandt","year":"1987","unstructured":"Brandt T, Dieterich M (1987) Pathological eye-head coordination in roll: tonic ocular tilt reaction in mesencephalic and medullary lesions. Brain 110:649\u2013666","journal-title":"Brain"},{"key":"7385_CR8","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/brain\/116.5.1095","volume":"116","author":"M Dieterich","year":"1993","unstructured":"Dieterich M, Brandt T (1993) Ocular torsion and perceived vertical in oculomotor, trochlear and abducens nerve palsies. Brain 116:1095\u20131104","journal-title":"Brain"},{"key":"7385_CR9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.410310409","volume":"31","author":"M Dieterich","year":"1992","unstructured":"Dieterich M, Brandt T (1992) Wallenberg\u2019s syndrome: lateropulsion, cyclorotation and subjective visual vertical in thirty-six patients. Ann Neurol 31:399\u2013408","journal-title":"Ann Neurol"},{"key":"7385_CR10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.410330311","volume":"33","author":"M Dieterich","year":"1993","unstructured":"Dieterich M, Brandt T (1993) Ocular torsion and tilt of subjective visual vertical are sensitive brainstem signs. Ann Neurol 33:292\u2013299","journal-title":"Ann Neurol"},{"key":"7385_CR11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1212\/WNL.40.10.1503","volume":"40","author":"GM Halmagyi","year":"1990","unstructured":"Halmagyi GM, Brandt T, Dieterich M, Curthoys IS, Stark RJ, Hoyt WF (1990) Tonic contraversive ocular tilt reaction due to unilateral meso-diencephalic lesion. Neurology 40:1503\u20131509","journal-title":"Neurology"},{"key":"7385_CR12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/jnnp.54.6.549","volume":"54","author":"T Brandt","year":"1991","unstructured":"Brandt T, Dieterich M (1991) Different types of skew deviation. J Neurol Neurosurg Psychiatry 54:549\u2013550","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7385_CR13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/WNO.0b013e3181677fcc","volume":"28","author":"MW Ko","year":"2008","unstructured":"Ko MW, Dalmau J, Galetta SL (2008) Neuro-ophthalmologic manifestations of paraneoplastic syndromes. J Neuroophthalmol 28:58\u201368","journal-title":"J Neuroophthalmol"},{"key":"7385_CR14","first-page":"388","volume":"31","author":"J Shallo-Hoffmann","year":"1990","unstructured":"Shallo-Hoffmann J, Schwarze H, Simonsz HJ, Muhlendyck H (1990) A reexamination of end-point and rebound nystagmus in normals. Invest Ophthalmol Vis Sci 31:388\u2013392","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7385_CR15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1196\/annals.1325.065","volume":"1039","author":"S Marti","year":"2005","unstructured":"Marti S, Straumann D, Glasauer S (2005) The origin of downbeat nystagmus: an asymmetry in the distribution of on-directions of vertical gaze-velocity purkinje cells. Ann N Y Acad Sci 1039:548\u2013553","journal-title":"Ann N Y Acad Sci"},{"key":"7385_CR16","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s10072-012-1155-1","volume":"33","author":"E Salsano","year":"2012","unstructured":"Salsano E, Umeh C, Rufa A, Pareyson D, Zee DS (2012) Vertical supranuclear gaze palsy in Niemann\u2013Pick type C disease. Neurol Sci 33:1225\u20131232","journal-title":"Neurol Sci"},{"key":"7385_CR17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archneur.1988.00520310043015","volume":"45","author":"GM Halmagyi","year":"1988","unstructured":"Halmagyi GM, Curthoys IS (1988) A clinical sign of canal paresis. Arch Neurol 45:737\u2013739","journal-title":"Arch Neurol"},{"key":"7385_CR18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archneur.1988.00520310043015","volume":"45","author":"GM Halmagyi","year":"2000","unstructured":"Halmagyi GM, Curthoys IS (2000) A clinical sign of canal paresis. Arch Neurol 45:737\u2013739","journal-title":"Arch Neurol"},{"key":"7385_CR19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1749-6632.2009.03850.x","volume":"1164","author":"K Bartl","year":"2009","unstructured":"Bartl K, Lehnen N, Kohlbecher S, Schneider E (2009) Head impulse testing using video-oculography. Ann N Y Acad Sci 1164:331\u2013333","journal-title":"Ann N Y Acad Sci"},{"key":"7385_CR20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00230111","volume":"81","author":"GM Gauthier","year":"1990","unstructured":"Gauthier GM, Vercher JL (1990) Visual vestibular interaction: vestibulo-ocular reflex suppression with head-fixed target fixation. Exp Brain Res 81:150\u2013160","journal-title":"Exp Brain Res"},{"key":"7385_CR21","first-page":"147","volume":"1","author":"AL Chen","year":"2010","unstructured":"Chen AL, Riley DE, King SA, Joshi AC, Serra A, Liao K, Cohen ML, Otero-Millan J, Martinez-Conde S, Strupp M, Leigh RJ (2010) The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis. Front Neurol 1:147","journal-title":"Front Neurol"},{"key":"7385_CR22","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/B978-0-444-59565-2.00041-1","volume":"113","author":"MT Vanier","year":"2013","unstructured":"Vanier MT (2013) Niemann\u2013Pick diseases. Handb Clin Neurol 113:1717\u20131721","journal-title":"Handb Clin Neurol"},{"key":"7385_CR23","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/ajmg.a.31735","volume":"143A","author":"WS Garver","year":"2007","unstructured":"Garver WS, Francis GA, Jelinek D, Shepherd G, Flynn J, Castro G, Walsh VC, Coppock DL, Pettit KM, Heidenreich RA, Meaney FJ (2007) The National Niemann\u2013Pick C1 disease database: report of clinical features and health problems. Am J Med Genet A 143A:1204\u20131211","journal-title":"Am J Med Genet A"},{"key":"7385_CR24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10409238.2011.636505","volume":"47","author":"G King","year":"2012","unstructured":"King G, Sharom FJ (2012) Proteins that bind and move lipids: MsbA and NPC1. Crit Rev Biochem Mol Biol 47:75\u201395","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"7385_CR25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/tra.12046","volume":"14","author":"S Poirier","year":"2013","unstructured":"Poirier S, Mayer G, Murphy SR, Garver WS, Chang TY, Schu P, Seidah NG (2013) The cytosolic adaptor AP-1A is essential for the trafficking and function of Niemann\u2013Pick type C proteins. Traffic 14:458\u2013469","journal-title":"Traffic"},{"key":"7385_CR26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/brain\/awl260","volume":"130","author":"M Sevin","year":"2007","unstructured":"Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, Sedel F (2007) The adult form of Niemann\u2013Pick disease type C. Brain 130:120\u2013133","journal-title":"Brain"},{"key":"7385_CR27","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1212\/01.wnl.0000345040.01917.9d","volume":"72","author":"LA Abel","year":"2009","unstructured":"Abel LA, Walterfang M, Fietz M, Bowman EA, Velakoulis D (2009) Saccades in adult Niemann\u2013Pick disease type C reflect frontal, brainstem, and biochemical deficits. Neurology 72:1083\u20131086","journal-title":"Neurology"},{"key":"7385_CR28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1196\/annals.1325.041","volume":"1039","author":"D Solomon","year":"2005","unstructured":"Solomon D, Winkelman AC, Zee DS, Gray L, Buttner-Ennever J (2005) Niemann\u2013Pick type C disease in two affected sisters: ocular motor recordings and brain-stem neuropathology. Ann N Y Acad Sci 1039:436\u2013445","journal-title":"Ann N Y Acad Sci"},{"key":"7385_CR29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1468-1331.2011.03545.x","volume":"19","author":"M Walterfang","year":"2012","unstructured":"Walterfang M, Macfarlane MD, Looi JC, Abel L, Bowman E, Fahey MC, Desmond P, Velakoulis D (2012) Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann\u2013Pick disease type C. Eur J Neurol 19:462\u2013467","journal-title":"Eur J Neurol"},{"key":"7385_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-8-12","volume":"8","author":"MC Patterson","year":"2013","unstructured":"Patterson MC, Mengel E, Wijburg FA, Muller A, Schwierin B, Drevon H, Vanier MT, Pineda M (2013) Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis 8:12","journal-title":"Orphanet J Rare Dis"},{"key":"7385_CR31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/13651501.2012.687451","volume":"16","author":"HH Klunemann","year":"2012","unstructured":"Klunemann HH, Santosh PJ, Sedel F (2012) Treatable metabolic psychoses that go undetected: what Niemann\u2013Pick type C can teach us. Int J Psychiatry Clin Pract 16:162\u2013169","journal-title":"Int J Psychiatry Clin Pract"},{"key":"7385_CR32","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","volume":"106","author":"MC Patterson","year":"2012","unstructured":"Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F (2012) Recommendations for the diagnosis and management of Niemann\u2013Pick disease type C: an update. Mol Genet Metab 106:330\u2013344","journal-title":"Mol Genet Metab"},{"key":"7385_CR33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","volume":"6","author":"MC Patterson","year":"2007","unstructured":"Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE (2007) Miglustat for treatment of Niemann\u2013Pick C disease: a randomised controlled study. Lancet Neurol 6:765\u2013772","journal-title":"Lancet Neurol"},{"key":"7385_CR34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ymgme.2009.07.003","volume":"98","author":"M Pineda","year":"2009","unstructured":"Pineda M, Wraith JE, Mengel E, Sedel F, Hwu WL, Rohrbach M, Bembi B, Walterfang M, Korenke GC, Marquardt T, Luzy C, Giorgino R, Patterson MC (2009) Miglustat in patients with Niemann\u2013Pick disease Type C (NP-C): a multicenter observational retrospective cohort study. Mol Genet Metab 98:243\u2013249","journal-title":"Mol Genet Metab"},{"key":"7385_CR35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2009.06.008","volume":"98","author":"JE Wraith","year":"2009","unstructured":"Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, Mengel E, Pineda M, Sedel F, Topcu M, Vanier MT, Widner H, Wijburg FA, Patterson MC (2009) Recommendations on the diagnosis and management of Niemann\u2013Pick disease type C. Mol Genet Metab 98:152\u2013165","journal-title":"Mol Genet Metab"},{"key":"7385_CR36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/CE.S20201","volume":"7","author":"CE Hollak","year":"2012","unstructured":"Hollak CE (2012) An evidence-based review of the potential benefits of taliglucerase alfa in the treatment of patients with Gaucher disease. Core Evid 7:15\u201320","journal-title":"Core Evid"},{"key":"7385_CR37","doi-asserted-by":"crossref","first-page":"e22410","DOI":"10.1371\/journal.pone.0022410","volume":"6","author":"W Benko","year":"2011","unstructured":"Benko W, Ries M, Wiggs EA, Brady RO, Schiffmann R, FitzGibbon EJ (2011) The saccadic and neurological deficits in type 3 Gaucher disease. PLoS One 6:e22410","journal-title":"PLoS One"},{"key":"7385_CR38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/B:BOLI.0000031101.12838.c6","volume":"27","author":"RJ Desnick","year":"2004","unstructured":"Desnick RJ (2004) Enzyme replacement and enhancement therapies for lysosomal diseases. J Inherit Metab Dis 27:385\u2013410","journal-title":"J Inherit Metab Dis"},{"key":"7385_CR39","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.21491","volume":"64","author":"R Schiffmann","year":"2008","unstructured":"Schiffmann R, FitzGibbon EJ, Harris C, DeVile C, Davies EH, Abel L, van Schaik IN, Benko W, Timmons M, Ries M, Vellodi A (2008) Randomized, controlled trial of miglustat in Gaucher\u2019s disease type 3. Ann Neurol 64:514\u2013522","journal-title":"Ann Neurol"},{"key":"7385_CR40","first-page":"1169","volume":"11","author":"TM Cox","year":"2010","unstructured":"Cox TM (2010) Eliglustat tartrate, an orally active glucocerebroside synthase inhibitor for the potential treatment of Gaucher disease and other lysosomal storage diseases. Curr Opin Investig Drugs 11:1169\u20131181","journal-title":"Curr Opin Investig Drugs"},{"key":"7385_CR41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1743-7075-10-34","volume":"10","author":"D Doneda","year":"2013","unstructured":"Doneda D, Netto CB, Moulin CC, Schwartz IV (2013) Effects of imiglucerase on the growth and metabolism of Gaucher disease type I patients: a systematic review. Nutr Metab (Lond) 10:34","journal-title":"Nutr Metab (Lond)"},{"key":"7385_CR42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/01.GIM.0000154300.84107.75","volume":"7","author":"O Neudorfer","year":"2005","unstructured":"Neudorfer O, Pastores GM, Zeng BJ, Gianutsos J, Zaroff CM, Kolodny EH (2005) Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients. Genet Med 7:119\u2013123","journal-title":"Genet Med"},{"key":"7385_CR43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-003-0925-3","volume":"250","author":"S Grosso","year":"2003","unstructured":"Grosso S, Farnetani MA, Berardi R, Margollicci M, Galluzzi P, Vivarelli R, Morgese G, Ballestri P (2003) GM2 gangliosidosis variant B1 neuroradiological findings. J Neurol 250:17\u201321","journal-title":"J Neurol"},{"key":"7385_CR44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10545-013-9618-y","volume":"36","author":"M Walterfang","year":"2013","unstructured":"Walterfang M, Bonnot O, Mocellin R, Velakoulis D (2013) The neuropsychiatry of inborn errors of metabolism. J Inherit Metab Dis 36:687\u2013702","journal-title":"J Inherit Metab Dis"},{"key":"7385_CR45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ymgme.2010.11.163","volume":"102","author":"E Osher","year":"2011","unstructured":"Osher E, Fattal-Valevski A, Sagie L, Urshanski N, Amir-Levi Y, Katzburg S, Peleg L, Lerman-Sagie T, Zimran A, Elstein D, Navon R, Stern N, Valevski A (2011) Pyrimethamine increases beta-hexosaminidase A activity in patients with Late Onset Tay Sachs. Mol Genet Metab 102:356\u2013363","journal-title":"Mol Genet Metab"},{"key":"7385_CR46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1017\/S0317167100013792","volume":"40","author":"MS Salman","year":"2013","unstructured":"Salman MS, Ikeda KM (2013) The syndrome of infantile-onset saccade initiation delay. Can J Neurol Sci 40:235\u2013240","journal-title":"Can J Neurol Sci"},{"key":"7385_CR47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bjo.80.2.151","volume":"80","author":"CM Harris","year":"1996","unstructured":"Harris CM, Shawkat F, Russell-Eggitt I, Wilson J, Taylor D (1996) Intermittent horizontal saccade failure (\u2018ocular motor apraxia\u2019) in children. Br J Ophthalmol 80:151\u2013158","journal-title":"Br J Ophthalmol"},{"key":"7385_CR48","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/brain\/awg283","volume":"126","author":"I Ber Le","year":"2003","unstructured":"Le Ber I, Moreira MC, Rivaud-Pechoux S, Chamayou C, Ochsner F, Kuntzer T, Tardieu M, Said G, Habert MO, Demarquay G, Tannier C, Beis JM, Brice A, Koenig M, Durr A (2003) Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. Brain 126:2761\u20132772","journal-title":"Brain"},{"key":"7385_CR49","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/brain\/awh080","volume":"127","author":"I Ber Le","year":"2004","unstructured":"Le Ber I, Bouslam N, Rivaud-Pechoux S, Guimaraes J, Benomar A, Chamayou C, Goizet C, Moreira MC, Klur S, Yahyaoui M, Agid Y, Koenig M, Stevanin G, Brice A, Durr A (2004) Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. Brain 127:759\u2013767","journal-title":"Brain"},{"key":"7385_CR50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12311-013-0463-1","volume":"12","author":"M Panouilleres","year":"2013","unstructured":"Panouilleres M, Frismand S, Sillan O, Urquizar C, Vighetto A, Pelisson D, Tilikete C (2013) Saccades and eye-head coordination in ataxia with oculomotor apraxia type 2. Cerebellum 12:557\u2013567","journal-title":"Cerebellum"},{"key":"7385_CR51","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(10)70183-6","volume":"9","author":"A Durr","year":"2010","unstructured":"Durr A (2010) Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 9:885\u2013894","journal-title":"Lancet Neurol"},{"key":"7385_CR52","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/mds.23559","volume":"26","author":"T Klockgether","year":"2011","unstructured":"Klockgether T, Paulson H (2011) Milestones in ataxia. Mov Disord 26:1134\u20131141","journal-title":"Mov Disord"},{"key":"7385_CR53","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ng0793-295","volume":"4","author":"S Gispert","year":"1993","unstructured":"Gispert S, Twells R, Orozco G, Brice A, Weber J, Heredero L, Scheufler K, Riley B, Allotey R, Nothers C (1993) Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet 4:295\u2013299","journal-title":"Nat Genet"},{"key":"7385_CR54","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0079-6123(08)00683-3","volume":"171","author":"S Geiner","year":"2008","unstructured":"Geiner S, Horn AK, Wadia NH, Sakai H, Buttner-Ennever JA (2008) The neuroanatomical basis of slow saccades in spinocerebellar ataxia type 2 (Wadia-subtype). Prog Brain Res 171:575\u2013581","journal-title":"Prog Brain Res"},{"key":"7385_CR55","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/mds.25464","volume":"28","author":"JS Kim","year":"2013","unstructured":"Kim JS, Kim JS, Youn J, Seo DW, Jeong Y, Kang JH, Park JH, Cho JW (2013) Ocular motor characteristics of different subtypes of spinocerebellar ataxia: distinguishing features. Mov Disord 28:1271\u20131277","journal-title":"Mov Disord"},{"key":"7385_CR56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2990.2007.00882.x","volume":"34","author":"U Rub","year":"2008","unstructured":"Rub U, Brunt ER, Seidel K, Gierga K, Mooy CM, Kettner M, Van Broeckhoven C, Bechmann I, La Spada AR, Schols L, den Dunnen W, de Vos RA, Deller T (2008) Spinocerebellar ataxia type 7 (SCA7): widespread brain damage in an adult-onset patient with progressive visual impairments in comparison with an adult-onset patient without visual impairments. Neuropathol Appl Neurobiol 34:155\u2013168","journal-title":"Neuropathol Appl Neurobiol"},{"key":"7385_CR57","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1007\/s00415-013-7016-x","volume":"260","author":"M Strupp","year":"2013","unstructured":"Strupp M, Teufel J, Habs M, Feuerecker R, Muth C, van de Warrenburg BP, Klopstock T, Feil K (2013) Effects of acetyl-dl-leucine in patients with cerebellar ataxia: a case series. J Neurol 260:2556\u20132561","journal-title":"J Neurol"},{"key":"7385_CR58","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00415-011-5999-8","volume":"258","author":"M Strupp","year":"2011","unstructured":"Strupp M, Thurtell MJ, Shaikh AG, Brandt T, Zee DS, Leigh RJ (2011) Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol 258:1207\u20131222","journal-title":"J Neurol"},{"key":"7385_CR59","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/brain\/awm067","volume":"130","author":"K Aure","year":"2007","unstructured":"Aure K, de Ogier BH, Laforet P, Jardel C, Eymard B, Lombes A (2007) Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression? Brain 130:1516\u20131524","journal-title":"Brain"},{"key":"7385_CR60","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/sj.eye.6703024","volume":"23","author":"S DeBrosse","year":"2009","unstructured":"DeBrosse S, Ubogu EE, Yaniglos S, Hassan MO, Leigh RJ (2009) Dynamic properties of eye movements in mitochondrial chronic progressive external ophthalmoplegia. Eye (Lond) 23:382\u2013388","journal-title":"Eye (Lond)"},{"key":"7385_CR61","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bjo.2009.165639","volume":"94","author":"AE Ritchie","year":"2010","unstructured":"Ritchie AE, Griffiths PG, Chinnery PF, Davidson AW (2010) Eye movement recordings to investigate a supranuclear component in chronic progressive external ophthalmoplegia: a cross-sectional study. Br J Ophthalmol 94:1165\u20131168","journal-title":"Br J Ophthalmol"},{"key":"7385_CR62","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJM198905183202001","volume":"320","author":"CT Moraes","year":"1989","unstructured":"Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, Nakase H, Bonilla E, Werneck LC, Servidei S (1989) Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 320:1293\u20131299","journal-title":"N Engl J Med"},{"key":"7385_CR63","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MD.0000000000000010","volume":"92","author":"C Compain","year":"2013","unstructured":"Compain C, Sacre K, Puechal X, Klein I, Vital-Durand D, Houeto JL, De BT, Raoult D, Papo T (2013) Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up. Medicine (Baltimore) 92:324\u2013330","journal-title":"Medicine (Baltimore)"},{"key":"7385_CR64","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410200605","volume":"20","author":"MA Schwartz","year":"1986","unstructured":"Schwartz MA, Selhorst JB, Ochs AL, Beck RW, Campbell WW, Harris JK, Waters B, Velasco ME (1986) Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple\u2019s disease. Ann Neurol 20:677\u2013683","journal-title":"Ann Neurol"},{"key":"7385_CR65","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s11910-003-0049-2","volume":"3","author":"ED Louis","year":"2003","unstructured":"Louis ED (2003) Whipple disease. Curr Neurol Neurosci Rep 3:470\u2013475","journal-title":"Curr Neurol Neurosci Rep"},{"key":"7385_CR66","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jnnp.2007.126284","volume":"79","author":"JN Wagner","year":"2008","unstructured":"Wagner JN, Glaser M, Brandt T, Strupp M (2008) Downbeat nystagmus: aetiology and comorbidity in 117 patients. J Neurol Neurosurg Psychiatry 79:672\u2013677","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7385_CR67","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1055\/s-0033-1354594","volume":"33","author":"M Strupp","year":"2013","unstructured":"Strupp M, Kremmyda O, Brandt T (2013) Pharmacotherapy of vestibular disorders and nystagmus. Semin Neurol 33:286\u2013296","journal-title":"Semin Neurol"},{"key":"7385_CR68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1212\/01.WNL.0000078893.41040.56","volume":"61","author":"M Strupp","year":"2003","unstructured":"Strupp M, Schuler O, Krafczyk S, Jahn K, Schautzer F, Buttner U, Brandt T (2003) Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 61:165\u2013170","journal-title":"Neurology"},{"key":"7385_CR69","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1212\/01.wnl.0000194242.28018.d9","volume":"66","author":"R Kalla","year":"2006","unstructured":"Kalla R, Deutschlander A, Hufner K, Stephan T, Jahn K, Glasauer S, Brandt T, Strupp M (2006) Detection of floccular hypometabolism in downbeat nystagmus by fMRI. Neurology 66:281\u2013283","journal-title":"Neurology"},{"key":"7385_CR70","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1136\/jnnp-2012-304736","volume":"84","author":"J Claassen","year":"2013","unstructured":"Claassen J, Spiegel R, Kalla R, Faldon M, Kennard C, Danchaivijitr C, Bardins S, Rettinger N, Schneider E, Brandt T, Jahn K, Teufel J, Strupp M, Bronstein A (2013) A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus\u2014effects on slowphase eye velocity, postural stability, locomotion and symptoms. J Neurol Neurosurg Psychiatry 84:1392\u20131399","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7385_CR71","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/brain\/awm172","volume":"130","author":"R Kalla","year":"2007","unstructured":"Kalla R, Glasauer S, Buttner U, Brandt T, Strupp M (2007) 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. Brain 130:2441\u20132451","journal-title":"Brain"},{"key":"7385_CR72","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s002210100788","volume":"139","author":"Y Etzion","year":"2001","unstructured":"Etzion Y, Grossman Y (2001) Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells. Exp Brain Res 139:419\u2013425","journal-title":"Exp Brain Res"},{"key":"7385_CR73","doi-asserted-by":"crossref","first-page":"7258","DOI":"10.1523\/JNEUROSCI.3582-09.2010","volume":"30","author":"K Alvina","year":"2010","unstructured":"Alvina K, Khodakhah K (2010) The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia. J Neurosci 30:7258\u20137268","journal-title":"J Neurosci"},{"key":"7385_CR74","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/jnnp.54.7.627","volume":"54","author":"M Dieterich","year":"1991","unstructured":"Dieterich M, Straube A, Brandt T, Paulus W, Buttner U (1991) The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psychiatry 54:627\u2013632","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7385_CR75","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/jnnp.2004.045716","volume":"76","author":"S Glasauer","year":"2005","unstructured":"Glasauer S, Kalla R, Buttner U, Strupp M, Brandt T (2005) 4-aminopyridine restores visual ocular motor function in upbeat nystagmus. J Neurol Neurosurg Psychiatry 76:451\u2013453","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-014-7385-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7385-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7385-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T04:58:50Z","timestamp":1565758730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-014-7385-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,22]]},"references-count":75,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["7385"],"URL":"https:\/\/doi.org\/10.1007\/s00415-014-7385-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,22]]}}}